Gamida Cell Ltd

(NASDAQ:GMDA)

Latest On Gamida Cell Ltd (GMDA):

Date/Time Type Description Signal Details
2023-05-22 22:17 ESTNewsGamida Cell gets new finance chiefN/A
2023-05-16 00:13 ESTNewsGamida Cell GAAP EPS of -$0.27 in-lineN/A
2023-05-16 00:13 ESTNewsGamida Cell Ltd. (GMDA) Q1 2023 Earnings Call TranscriptN/A
2023-04-28 19:53 ESTNewsGamida: The Die Is Now CastN/A
2023-04-19 11:08 ESTNewsGamida Cell stock dips after pricing $23M securities offeringN/A
2023-04-18 23:26 ESTNewsHot Stocks: BLU rises on buy out offer from GSK; ERIC slips on earnings; NVDA, GMDA gains; MP slidesN/A
2023-04-17 21:56 ESTNewsGamida cell therapy Omisirge for blood cancer patients approved by FDAN/A
2023-03-27 15:34 ESTNewsGamida Cell GAAP EPS of -$1.24 misses by $0.05N/A
2023-03-27 15:34 ESTNewsGamida Cell Ltd. (GMDA) Q4 2023 Earnings Call TranscriptN/A
2023-03-27 15:34 ESTNewsGamida Cell tanks after dismal cash runway guidance for 2023N/A
2023-03-25 02:34 ESTNewsGamida Cell FY 2022 Earnings PreviewN/A
2023-03-21 05:08 ESTNewsGamida Cell names Shawn Cline Tomasello chairwomanN/A
2022-11-22 20:48 ESTNewsGamida Cell sheds 21% as FDA extends review for lead candidateN/A
2022-11-15 02:38 ESTNewsGamida Cell Ltd. (GMDA)Q3 2022 Earnings Call TranscriptN/A
2022-11-14 09:16 ESTNewsGamida Cell GAAP EPS of -$0.29 beats by $0.02N/A
2022-11-13 17:26 ESTNewsGamida Cell Q3 2022 Earnings PreviewN/A
2022-11-07 19:18 ESTNewsGamida's rises 5% after cell therapy candidate GDA-501 shows promising antitumor activity against HER2+ cancersN/A
2022-09-30 02:22 ESTNewsGamida Cell gains on long-term data for blood cancer therapyN/A
2022-09-28 19:23 ESTNewsGamida Cell shares slide on pricing ~$20M stock offeringN/A
2022-09-28 19:23 ESTNewsGamida gets $25M debt financing commitment from Highbridge CapitalN/A
2022-09-28 03:43 ESTNewsGamida Cell shares slide after stock offeringN/A
2022-09-19 23:24 ESTNewsGamida appoints Emergent’s former head of vaccines as new CEON/A
2022-08-17 01:41 ESTNewsGamida Cell: Gearing Up For FDA ApprovalN/A
2022-08-15 15:52 ESTNewsGamida Cell GAAP EPS of -$0.31 misses by $0.02N/A
2022-08-15 15:52 ESTNewsGamida Cell Ltd. (GMDA) CEO Julian Adams on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-12 19:42 ESTNewsGamida Cell Q2 2022 Earnings PreviewN/A
2022-08-01 11:02 ESTNewsGamida stock rises 13% as FDA grants priority review to stem cell therapy omidubicelN/A
2022-06-25 02:23 ESTNewsGamida Cell (GMDA) Investor Presentation- SlideshowN/A
2022-06-03 01:58 ESTNewsGamida Cell completes rolling submission to the FDA for omidubicelN/A
2022-05-11 04:04 ESTNewsGamida Cell GAAP EPS of -$0.34 in-lineN/A
2022-05-11 04:04 ESTNewsGamida Cell Ltd. (GMDA) Management on Q1 2022 Results - Earnings Call TranscriptN/A
2022-04-27 22:51 ESTNewsGamida Cell stock falls a day after soaring on FDA lifting clinical hold on GDA-201N/A
2022-04-26 13:01 ESTNewsGamida stock soars 32% as FDA lifts hold on GDA-201, to start trial for treating blood cancerN/A
2022-03-16 01:13 ESTNewsGamida Cell GAAP EPS of -$1.52 misses by $0.10N/A
2022-03-16 01:12 ESTNewsGamida Cell Ltd. (GMDA) CEO Julian Adams on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-10 08:49 ESTNewsGamida Cell surges 22% following rolling BLA submission for omidubicelN/A
2022-02-09 12:12 ESTNewsGamida Cell begins rolling submission with FDA for omidubicel for stem cell transplantN/A
2022-01-31 17:33 ESTNewsGamida Cell provides key program updates and 2022 outlookN/A
2022-01-19 12:47 ESTNewsGamida Cell plans rolling BLA submission for omidubicel for blood cancers; shares up 18%N/A
2021-12-06 16:05 ESTNewsGamida Cell (GMDA) Investor Presentation - SlideshowN/A
2021-11-19 12:56 ESTNewsGamida Cell Ltd. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-16 01:38 ESTNewsGamida Cell EPS beats by $0.14N/A
2021-11-16 01:37 ESTNewsGamida Cell Ltd (GMDA) CEO Julian Adams on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-02 16:41 ESTNewsGamida Cell: Recapping A Tough YearN/A
2021-08-11 21:21 ESTNewsGamida Cell EPS misses by $0.36N/A
2021-08-11 21:18 ESTNewsGamida Cell Ltd. 2021 Q2 - Results - Earnings Call PresentationN/A
2021-08-11 21:18 ESTNewsGamida Cell Ltd (GMDA) CEO Julian Adams on Q2 2021 Results - Earnings Call TranscriptN/A
2021-04-15 20:11 ESTNewsGamida Cell (GMDA) Presents At 20th Annual Needham Virtual Healthcare Conference - SlideshowN/A
2021-03-11 15:42 ESTFinancialsCompany financials have been released.Neutral
2021-03-11 11:41 ESTAnalyst RatingThe Analyst Target Price has increased from $18.67 to $19.Buy

About Gamida Cell Ltd (GMDA):

Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company's lead product candidate is omidubicel, a cell therapy that is in Phase III studies in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, a natural killer cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. The company was founded in 1998 and is headquartered in Jerusalem, Israel.

GMDA Quotes by TradingView

See Advanced Chart

General

  • Name Gamida Cell Ltd
  • Symbol GMDA
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 110
  • Fiscal Year EndDecember
  • IPO Date2018-10-26
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.gamida-cell.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 5.23
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.78
  • Next Year EPS Estimate -$1.97
  • Next Quarter EPS Estimate -$0.33
  • Return on Assets -35%
  • Return on Equity -109%
  • Earnings Per Share -$3.20
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 515.63 million
  • EBITDA -38606000
  • Analyst Target Price $19
  • Book Value Per Share $1.67
View More

Share Statistics

  • Shares Outstanding 59.2 million
  • Shares Float 41.1 million
  • % Held by Insiders 3184%
  • % Held by Institutions 33.63%
  • Shares Short 1.14 million
  • Shares Short Prior Month 1.33 million
  • Short Ratio 0.65
  • Short % of Float 2%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 2.04
  • 52 Week High $12.47
  • 52 Week Low $2.73
  • 50 Day Moving Average 9.56
  • 200 Day Moving Average 7.32
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Gamida Cell Ltd (GMDA) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Gamida Cell Ltd (GMDA) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-09$N/A-$0.68-$0.34-98.08%
2020-09-302020-11-10$N/A-$0.30-$0.314.25%
2020-06-302020-08-11$N/A-$0.37-$0.30-24.71%
2020-03-312020-05-21$N/A-$0.31-$0.4530.8%
2019-12-312020-02-25$N/A-$0.47-$0.36-32.39%
2019-09-302019-11-13$N/A-$0.30-$0.3412.41%
2019-06-302019-08-06$N/A$0.23-$0.44152.27%
2019-03-312019-05-07$N/A-$0.62-$0.40-55%
2018-12-312019-02-25$N/A-$0.35-$0.387.97%

Gamida Cell Ltd (GMDA) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development N/A N/A 9.32 million 7.88 million 9.78 million
Income Before Tax N/A N/A -15.06 million -10.6 million -14.71 million
Selling General Administrative N/A N/A 2.5 million 2.99 million 4.59 million
Gross Profit N/A N/A N/A N/A N/A
Ebit N/A N/A -12.18 million -9.13 million -14.37 million
Operating Income N/A N/A -12.84 million -12.34 million -14.37 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A N/A N/A N/A -342000
Net Income From Continuing Operations N/A N/A -15.06 million -10.6 million -14.71 million
Net Income Applicable to Common Shares -32.3 million -14.75 million N/A N/A -14.71 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A -4.99 million 11.43 million 14.95 million -23.97 million
Change to Liabilities -39000 N/A N/A -941000 -124000
Total Cash Flow from Investing Activities -2.68 million N/A N/A 14.04 million -25.23 million
Net Borrowings -417000 N/A N/A -385000 -380000
Total Cash Flow from Financial Activities N/A 63.81 million -728000 -446000 37 million
Change to Operating Activities 1.49 million N/A N/A 1.86 million 514000
Change in Cash N/A 48.35 million -1.55 million 2.27 million 2.5 million
Total Cash from Operating Activities -12.28 million -10.45 million -12.33 million -11.32 million -9.29 million
Depreciation N/A 556000 550000 351000 547000
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities N/A N/A N/A 22000 35000
Change to Net Income 414000 N/A N/A 2.11 million -129000
Capital Expenditures N/A 4.99 million 2.12 million 916000 1.26 million
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities N/A N/A 38.67 million 31.65 million 33.79 million
Total Stockholder Equity N/A N/A 74.55 million 25.28 million 34.98 million
Other Current Liabilities N/A N/A N/A N/A N/A
Total Assets N/A N/A 113.22 million 56.93 million 68.78 million
Common Stock 166000 60.57 million N/A N/A 92000
Other Current Assets N/A N/A N/A N/A N/A
Retained Earnings -276.27 million N/A -229.22 million N/A -203.56 million
Other Liabilities 29.81 million 18.75 million N/A N/A 18.3 million
Other Assets 786000 802000 N/A N/A 641000
Cash N/A N/A 88.64 million 40.29 million 41.84 million
Total Current Liabilities 21.55 million 13.93 million 13.58 million 10.1 million 11.4 million
Other Stockholder Equity -441000 N/A N/A N/A -537000
Property, Plant & Equipment 24.71 million 22.86 million N/A N/A 11.43 million
Total Current Assets 129.99 million 75.05 million 90.88 million 41.93 million 56.7 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 98.74 million 60.57 million N/A N/A 34.98 million
Short Term Investments N/A N/A N/A N/A 13.56 million
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 6.33 million 2.7 million 2.74 million 3.1 million 1.16 million

Gamida Cell Ltd (GMDA) Chart:

Gamida Cell Ltd (GMDA) News:

Below you will find a list of latest news for Gamida Cell Ltd (GMDA) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Gamida Cell Ltd (GMDA) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-170.50.05CALL1 2480FALSE00
2024-05-1710CALL0 00FALSE00
2024-05-1720.5CALL1 10FALSE00
2024-05-1730CALL0 00FALSE00
2024-05-170.50PUT0 00TRUE00
2024-05-1710PUT0 00TRUE00
2024-05-1721.95PUT1 10TRUE00
2024-05-1733PUT2 10TRUE00
2024-06-210.50.03CALL10 5620FALSE00
2024-06-2110.1CALL20 12660FALSE00
2024-06-2120.05CALL5 1690FALSE00
2024-06-2130.1CALL250 2540FALSE00
2024-06-2140CALL0 00FALSE00
2024-06-210.50.45PUT5 50TRUE00
2024-06-2110.72PUT2 510TRUE00
2024-06-2120PUT0 00TRUE00
2024-06-2130PUT0 00TRUE00
2024-06-2140PUT0 00TRUE00
2024-09-200.50.25CALL10 130FALSE00
2024-09-2010.05CALL10 2880FALSE00
2024-09-2020CALL0 00FALSE00
2024-09-2030.1CALL0 100FALSE00
2024-09-200.50.45PUT5 8361.16TRUE00
2024-09-2010.7PUT5 390TRUE00
2024-09-2020PUT0 00TRUE00
2024-09-2030PUT0 00TRUE00
2025-01-170.50.05CALL10 3983507.17FALSE0.02-0.4
2025-01-1710.03CALL1 1650FALSE00
2025-01-171.50CALL0 00FALSE00
2025-01-1720.1CALL1 320FALSE00
2025-01-170.50.45PUT1 659299.24TRUE00
2025-01-1710.87PUT1 20TRUE00
2025-01-171.50PUT0 00TRUE00
2025-01-1720PUT0 00TRUE00
2026-01-160.50.05CALL111 56450FALSE00
2026-01-1610.1CALL10 2140FALSE00
2026-01-161.50CALL0 00FALSE00
2026-01-1620.08CALL1 150FALSE00
2026-01-1630.09CALL65 12180FALSE00
2026-01-160.50.45PUT10 734236.03TRUE00
2026-01-1610.91PUT1 20TRUE00
2026-01-161.50PUT0 00TRUE00
2026-01-1620PUT0 00TRUE00
2026-01-1630PUT0 00TRUE00

Latest GMDA Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST42$1.98
Jun 13, 2022 7:59 PM EST22$1.98
Jun 13, 2022 7:59 PM EST4$1.985
Jun 13, 2022 7:59 PM EST54$1.985
Jun 13, 2022 7:59 PM EST4$1.985

Gamida Cell Ltd (GMDA) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-05-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020013408/0001213900-20-013408-index.htm
2018-06-27UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1600847/000000000018019736/0000000000-18-019736-index.htm
2018-07-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1600847/000000000018021963/0000000000-18-021963-index.htm
2018-09-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1600847/000000000018027851/0000000000-18-027851-index.htm
2018-10-10UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1600847/000000000018031744/0000000000-18-031744-index.htm
2019-02-25UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1600847/000000000019003108/0000000000-19-003108-index.htm
2019-11-22UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1600847/000000000019015775/0000000000-19-015775-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600847/000031506620000975/0000315066-20-000975-index.htm
2020-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600847/000031506620001643/0000315066-20-001643-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600847/000090571819000211/0000905718-19-000211-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600847/000090571820000245/0000905718-20-000245-index.htm
2018-11-08SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600847/000110465918067019/0001104659-18-067019-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600847/000110465920020959/0001104659-20-020959-index.htm
2020-08-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600847/000110465920095611/0001104659-20-095611-index.htm
2018-06-01DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1600847/000114036118026660/0001140361-18-026660-index.htm
2018-07-03DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1600847/000114036118031249/0001140361-18-031249-index.htm
2018-07-03DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1600847/000114036118031250/0001140361-18-031250-index.htm
2018-08-24DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1600847/000114036118036942/0001140361-18-036942-index.htm
2018-08-24DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1600847/000114036118036944/0001140361-18-036944-index.htm
2018-09-28F-1Registration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1600847/000114036118039574/0001140361-18-039574-index.htm
2018-09-28CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1600847/000114036118039578/0001140361-18-039578-index.htm
2018-10-09CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1600847/000114036118040254/0001140361-18-040254-index.htm
2018-10-17F-1/ARegistration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1600847/000114036118040749/0001140361-18-040749-index.htm
2018-10-17CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1600847/000114036118040751/0001140361-18-040751-index.htm
2018-10-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1600847/000114036118041132/0001140361-18-041132-index.htm
2018-10-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1600847/000114036118041133/0001140361-18-041133-index.htm
2018-10-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1600847/000114036118041134/0001140361-18-041134-index.htm
2018-10-238-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1600847/000114036118041135/0001140361-18-041135-index.htm
2018-10-26FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1600847/000114036118041364/0001140361-18-041364-index.htm
2018-10-30424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1600847/000114036118041581/0001140361-18-041581-index.htm
2018-11-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036118042068/0001140361-18-042068-index.htm
2018-11-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1600847/000114036118042831/0001140361-18-042831-index.htm
2018-11-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036118043805/0001140361-18-043805-index.htm
2019-01-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119000496/0001140361-19-000496-index.htm
2019-01-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119001569/0001140361-19-001569-index.htm
2019-02-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119002703/0001140361-19-002703-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600847/000114036119003275/0001140361-19-003275-index.htm
2019-02-15DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1600847/000114036119003384/0001140361-19-003384-index.htm
2019-02-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119003438/0001140361-19-003438-index.htm
2019-02-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119003625/0001140361-19-003625-index.htm
2019-02-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119003721/0001140361-19-003721-index.htm
2019-02-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119003780/0001140361-19-003780-index.htm
2019-02-2520-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1600847/000114036119003787/0001140361-19-003787-index.htm
2019-04-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600847/000114036119006807/0001140361-19-006807-index.htm
2019-05-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119008107/0001140361-19-008107-index.htm
2019-05-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119008557/0001140361-19-008557-index.htm
2019-05-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119010144/0001140361-19-010144-index.htm
2019-06-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119010397/0001140361-19-010397-index.htm
2019-06-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119010449/0001140361-19-010449-index.htm
2019-06-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119010604/0001140361-19-010604-index.htm
2019-06-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119011249/0001140361-19-011249-index.htm
2019-06-24F-1Registration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1600847/000114036119011438/0001140361-19-011438-index.htm
2019-06-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1600847/000114036119011443/0001140361-19-011443-index.htm
2019-06-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1600847/000114036119011444/0001140361-19-011444-index.htm
2019-06-26F-1/ARegistration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1600847/000114036119011535/0001140361-19-011535-index.htm
2019-06-26F-1MEFRegistration statement to add securities to prior Form F-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1600847/000114036119011725/0001140361-19-011725-index.htm
2019-06-28424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1600847/000114036119011945/0001140361-19-011945-index.htm
2019-07-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119012525/0001140361-19-012525-index.htm
2019-08-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119014449/0001140361-19-014449-index.htm
2019-09-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119016530/0001140361-19-016530-index.htm
2014-03-06DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1600847/000117891314000868/0001178913-14-000868-index.htm
2014-06-12DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1600847/000117891314002038/0001178913-14-002038-index.htm
2018-11-09SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600847/000119312518323751/0001193125-18-323751-index.htm
2019-07-03SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600847/000119312519189228/0001193125-19-189228-index.htm
2020-05-22SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600847/000119312520149860/0001193125-20-149860-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600847/000121390019002422/0001213900-19-002422-index.htm
2019-11-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390019023226/0001213900-19-023226-index.htm
2019-11-14F-3Registration statement by foreign private issuershttps://www.sec.gov/Archives/edgar/data/1600847/000121390019023541/0001213900-19-023541-index.htm
2019-11-25CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1600847/000121390019024600/0001213900-19-024600-index.htm
2019-12-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390019025616/0001213900-19-025616-index.htm
2020-01-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020000071/0001213900-20-000071-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020000889/0001213900-20-000889-index.htm
2020-02-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020004763/0001213900-20-004763-index.htm
2020-02-2620-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1600847/000121390020004776/0001213900-20-004776-index.htm
2020-05-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1600847/000121390020011448/0001213900-20-011448-index.htm
2020-05-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020011751/0001213900-20-011751-index.htm
2020-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020012389/0001213900-20-012389-index.htm
2020-05-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1600847/000121390020012807/0001213900-20-012807-index.htm
2020-05-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020012815/0001213900-20-012815-index.htm
2020-05-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1600847/000121390020013082/0001213900-20-013082-index.htm
2020-05-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020013095/0001213900-20-013095-index.htm
2020-05-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020013191/0001213900-20-013191-index.htm
2020-05-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020013408/0001213900-20-013408-index.htm
2020-07-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020017331/0001213900-20-017331-index.htm
2020-07-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020018044/0001213900-20-018044-index.htm
2020-08-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020020641/0001213900-20-020641-index.htm
2020-08-106-K/AReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020021158/0001213900-20-021158-index.htm
2020-08-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020021526/0001213900-20-021526-index.htm
2020-09-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020026019/0001213900-20-026019-index.htm
2020-09-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020026442/0001213900-20-026442-index.htm
2020-10-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020030199/0001213900-20-030199-index.htm
2020-10-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020030978/0001213900-20-030978-index.htm
2020-11-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020034410/0001213900-20-034410-index.htm
2020-11-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020035176/0001213900-20-035176-index.htm
2018-10-24CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1600847/000135445718000430/0001354457-18-000430-index.htm
2019-03-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000156761919007391/0001567619-19-007391-index.htm
2018-10-26EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1600847/999999999518002726/9999999995-18-002726-index.htm
2019-06-26EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1600847/999999999519001454/9999999995-19-001454-index.htm
2019-11-27EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1600847/999999999519002687/9999999995-19-002687-index.htm
2018-10-29CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1600847/999999999718008816/9999999997-18-008816-index.htm